FA
CDAK
Forefront Analytics’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-110,210
| Closed | -$19.2K | – | 80 |
|
|
2023
Q1 | $19.2K | Buy |
110,210
+10,275
| +10% | +$1.79K | 0.01% | 79 |
|
|
2022
Q4 | $39.7K | Buy |
99,935
+43,450
| +77% | +$17.3K | 0.02% | 70 |
|
|
2022
Q3 | $47K | Buy |
56,485
+38,175
| +208% | +$31.8K | 0.03% | 64 |
|
|
2022
Q2 | $57K | Sell |
18,310
-1,000
| -5% | -$3.11K | 0.03% | 63 |
|
|
2022
Q1 | $122K | Buy |
+19,310
| New | +$122K | 0.05% | 57 |
|